Increased activation of NFκB may contribute to the pathology in models of Parkinson's disease [39]–[41], [51]; therefore, it is possible that protection of striatal TH+ fibers by NAC treatment may be linked to reduced NFκB activity in these animals. Here, NFKB1 is linked to Parkinson disease.